The Oncology Association ranked 40 drugs and their labels ahead of the basket committee discussions • At the top of the list: treatments for bladder, breast and digestive tract cancer • The doctors warn of a growing gap with countries in the world and between those with private insurance and patients dependent on public medicine: "raising a red flag"